~36 spots leftby Jan 2027

Nutrition Programs for Cognitive Impairment

JL
JL
Overseen ByJulia L Sheffler, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Florida State University
Must not be taking: Anticonvulsants, Anticholinergics, Immunosuppressants, others
Disqualifiers: Neurodegenerative illness, Major psychiatric disorder, Type 1 diabetes, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial tests two diets on older adults in rural Black and African-American communities in North Florida. One diet is rich in natural foods, while the other also helps the body burn fat for energy. Researchers want to see if these diets can improve health and brain function.

Will I have to stop taking my current medications?

The trial requires that participants be stable on their medications for at least 4 weeks before the screening visit, but it does not specify if you need to stop taking them. However, certain medications like Warfarin, insulin, and some others are not allowed.

What data supports the effectiveness of the treatment Mediterranean Nutrition Adherence Program and similar diets for cognitive impairment?

Research suggests that adherence to a Mediterranean diet, which is part of the Mediterranean Nutrition Adherence Program, may be associated with better cognitive performance in older adults. Studies have shown that this diet can improve cognitive function over time, particularly in those with high cardiovascular disease risk.12345

Is the Mediterranean or Mediterranean-Ketogenic diet safe for humans?

The Mediterranean and Mediterranean-Ketogenic diets have been studied in various contexts, including cognitive function and dementia risk, and are generally considered safe for humans. Participants in studies often report high satisfaction with these diets, and they are associated with positive health outcomes without significant safety concerns.13678

How does the Mediterranean-Ketogenic Nutrition treatment differ from other treatments for cognitive impairment?

The Mediterranean-Ketogenic Nutrition treatment is unique because it combines the benefits of the Mediterranean diet with a ketogenic approach, potentially targeting multiple brain-related mechanisms linked to dementia risk. This treatment also incorporates motivational interviewing and behavior change techniques to improve adherence, which may enhance its effectiveness compared to standard nutrition education programs.12479

Eligibility Criteria

This trial is for adults aged 55-85 with mild cognitive impairment or early Alzheimer's, who are interested in a nutrition program. They should have stable health and medication use for some time before the study starts. The trial focuses on Black and African-American communities in rural North Florida.

Inclusion Criteria

If you scored between 17 and 26 on the MoCA test, you may not be able to participate. If you scored 27 or higher, you may be eligible.
I am between 55 and 85 years old.
My medications have been stable for at least 4 weeks.
See 3 more

Treatment Details

Interventions

  • Mediterranean Nutrition Adherence Program (Behavioral Intervention)
  • Modified Mediterranean Ketogenic Nutrition Adherence Program (Behavioral Intervention)
Trial OverviewThe study tests two diets: a Mediterranean diet and a modified ketogenic version of it, to see which one better adheres to participants' lifestyles. It also looks at how these diets affect gut-brain markers related to Alzheimer's disease over a 10-week period.
Participant Groups
4Treatment groups
Experimental Treatment
Active Control
Group I: MKN Adherence Program + Maintenance Opt 2Experimental Treatment1 Intervention
The M-KN adherence program will consist of 10, 1-hour weekly group meetings, which will take place via HIPAA-compliant Zoom. Sessions will be devoted to providing nutrition information, building group support, identifying participant goals, and working as a group to overcome barriers. Participants will be provided with access to an online forum after the program.
Group II: MKN Adherence Program + Maintenance Opt 1Experimental Treatment1 Intervention
The M-KN adherence program will consist of 10, 1-hour weekly group meetings, which will take place via HIPAA-compliant Zoom. Sessions will be devoted to providing nutrition information, building group support, identifying participant goals, and working as a group to overcome barriers. Participants will be provided with access to ongoing monthly support groups after the 10-week program ends and/or continued use of an online forum after the program.
Group III: Mediterranean Adherence Program + Maintenance Opt 1Active Control1 Intervention
The Mediterranean adherence program will consist of 10, 1-hour weekly group meetings, which will take place via HIPAA-compliant Zoom. Sessions will be devoted to providing nutrition information, building group support, identifying participant goals, and working as a group to overcome barriers. Participants will be provided with access to ongoing monthly support groups after the 10-week program ends and/or continued use of an online forum after the program.
Group IV: Mediterranean Adherence Program + Maintenance Opt 2Active Control1 Intervention
The Mediterranean adherence program will consist of 10, 1-hour weekly group meetings, which will take place via HIPAA-compliant Zoom. Sessions will be devoted to providing nutrition information, building group support, identifying participant goals, and working as a group to overcome barriers. Participants will be provided with access to an online forum after the program.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Florida State University

Lead Sponsor

Trials
234
Recruited
41,100+

Findings from Research

The Mediterranean ketogenic nutrition (MKN) program that included motivational interviewing and behavior change techniques led to higher participant retention (82%) and attendance (91%) compared to a standard education program, indicating it may be more effective in engaging older adults with memory concerns.
Participants in the MKN Adherence program showed better adherence to the diet and some clinical benefits, although these benefits were less pronounced at the 3-month follow-up, suggesting that ongoing support may be necessary for sustained effects.
Improving Adherence to a Mediterranean Ketogenic Nutrition Program for High-Risk Older Adults: A Pilot Randomized Trial.Sheffler, JL., Kiosses, DN., He, Z., et al.[2023]
A 6-week ketogenic nutrition adherence program was successfully completed by all 9 older adults (ages 64-75) with mild cognitive impairment, showing high adherence and measurable ketone levels in 8 participants.
Significant improvements in cognitive performance were observed, with a median score increase from 88 to 96, indicating potential benefits of the ketogenic diet for cognitive function in this population.
Feasibility of an MI-CBT ketogenic adherence program for older adults with mild cognitive impairment.Sheffler, JL., Arjmandi, B., Quinn, J., et al.[2022]
Adherence to the Mediterranean Diet (aMED) was linked to a significantly lower risk of cognitive impairment in a study of 7,756 participants, with odds ratios indicating a strong protective effect against cognitive decline.
Higher fish intake was associated with better cognitive function and a slower rate of cognitive decline over 5 to 10 years, suggesting that specific dietary components may enhance cognitive health.
Adherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2.Keenan, TD., Agrón, E., Mares, JA., et al.[2022]

References

Improving Adherence to a Mediterranean Ketogenic Nutrition Program for High-Risk Older Adults: A Pilot Randomized Trial. [2023]
Feasibility of an MI-CBT ketogenic adherence program for older adults with mild cognitive impairment. [2022]
Adherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2. [2022]
Mediterranean, DASH, and MIND Dietary Patterns and Cognitive Function: The 2-Year Longitudinal Changes in an Older Spanish Cohort. [2023]
MedDiet adherence score for the association between inflammatory markers and cognitive performance in the elderly: a study of the NHANES 2011-2014. [2022]
Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults. [2022]
Long-term adherence to the Mediterranean diet is associated with overall cognitive status, but not cognitive decline, in women. [2023]
Effect of Dietary Intake Through Whole Foods on Cognitive Function: Review of Randomized Controlled Trials. [2022]
The Impact of Nutrition on Cognitive Performance in a Frail Elderly Population Living in Northern Italy. [2023]